Health Condition 1: G301- Alzheimers disease with late onset Health Condition 2: G20- Parkinsons disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects with age (20-60 yrs.) without PD and AD. (2) Both sex is included. (3) Subjects without any chronic complications are included. (4)Subjects without Parkinson and Alzheimer and any other systemic diseases such as diabetes were included.
Exclusion criteria
Exclusion criteria: (1) Subjects who did not accept voluntarily to sign the consent form were excluded. (2) Subjects with any health complications and infectious disorders are excluded. (3) Pregnant women are excluded. (4) Subjects with Smoking and alcohol consumption/HIV/Cancer/Hepatitis/ autoimmune disorders excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study is designed for the detection of protein biomarkers in subjects with neurodegenerative disorders by fluorescence spectroscopyTimepoint: Baseline for Control Baseline for Test | — |
Secondary
| Measure | Time frame |
|---|---|
| Standardization of deviceTimepoint: 12 Months;To detect protein aggregates in Alzheimer’s and Parkinson’s diagnosis and controls Timepoint: 12 months | — |
Countries
India
Contacts
Manipal School of Life Sciences, Manipal Academy of Higher Education